In Concert For Cancer
EIN: 880884317 · Kenmore, WA · NTEE: E60
| Metric | Value |
|---|---|
| Total Revenue | $371K |
| Total Expenses | $132K |
| Net Assets | $242K |
Is In Concert For Cancer Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About In Concert For Cancer
In Concert For Cancer (EIN: 880884317) is a nonprofit organization based in Kenmore, WA, classified under NTEE code E60. The organization reported total revenue of $371K and total assets of $492K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of In Concert For Cancer's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
In Concert For Cancer is a small nonprofit that has been operating for 4 years, with 2 years of IRS 990 filings on record (2022–2023). Revenue has grown at a compound annual rate of 119.4%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $221K |
| Total Expenses | $132K |
| Surplus / Deficit | +$89K |
| Total Assets | $242K |
| Net Assets | $242K |
| Operating Margin | 40.2% |
| Months of Reserves | 22.1 months |
Financial Health Grade: A
In 2023, In Concert For Cancer reported a surplus of $89K with revenue exceeding expenses, holds 22.1 months of operating reserves (strong position).
Financial Trends
Over 2 years of filings (2022–2023), In Concert For Cancer's revenue has grown at a compound annual growth rate (CAGR) of 119.4%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +119.4% | +170.8% | +57.6% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2022 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for In Concert For Cancer has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates In Concert For Cancer with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $89K, with revenue exceeding expenses.
Frequently Asked Questions about In Concert For Cancer
Is In Concert For Cancer a legitimate charity?
Based on AI analysis of IRS 990 filings, In Concert For Cancer (EIN: 880884317) insufficient data. 0 red flags identified, 0 strengths noted.
How does In Concert For Cancer spend its money?
Detailed spending breakdown data is not yet available for In Concert For Cancer. Check back for updated IRS 990 analysis.
Are donations to In Concert For Cancer tax-deductible?
In Concert For Cancer is registered as a tax-exempt nonprofit (EIN: 880884317). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is In Concert For Cancer located?
In Concert For Cancer is headquartered in Kenmore, Washington and files with the IRS under EIN 880884317. It is classified under NTEE code E60.
How many years of IRS 990 filings does In Concert For Cancer have?
In Concert For Cancer has 2 years of IRS 990 filings on record at NonprofitSpending. Additional filing years may become available as the IRS releases new data. The most recent filing shows $371K in total revenue.
Filing History
IRS 990 filing history for In Concert For Cancer showing financial trends over 2 years of public records:
Over 2 years of IRS 990 filings (2022–2023), In Concert For Cancer's revenue has grown by 119.4%, moving from $100K to $221K. Total assets increased by 57.6% over the same period, from $154K to $242K. Total functional expenses rose by 170.8%, from $49K to $132K. In its most recent filing year (2023), In Concert For Cancer reported a surplus of $89K, with revenue exceeding expenses.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $221K | $132K | $242K | $0 | — | View 990 |
| 2022 | $100K | $49K | $154K | $0 | — | View 990 |
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for In Concert For Cancer:
Data Sources and Methodology
This transparency report for In Concert For Cancer is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.